Home Anti-Alzheimer, antioxidants, glucose-6-phosphate dehydrogenase effects of Taverniera glabra mediated ZnO and Fe2O3 nanoparticles in alloxan-induced diabetic rats
Article Open Access

Anti-Alzheimer, antioxidants, glucose-6-phosphate dehydrogenase effects of Taverniera glabra mediated ZnO and Fe2O3 nanoparticles in alloxan-induced diabetic rats

  • Aziz Ullah Khan , Mohamed Mohany , Hidayat Ullah Khan EMAIL logo , Fozia Fozia , Shahnaz Khan , Naveed Kamran , Fahim Ullah Khan , Salim S. Al-Rejaie , Ijaz Ahmad , Nouf S. S. Zaghloul and Mourad A. M. Aboul-Soud EMAIL logo
Published/Copyright: March 13, 2023

Abstract

The current study aimed to assess the neuroprotective effect of Zn and Fe oxide nanoparticles biofabricated by Taverniera glabra in alloxan-induced diabetic rats. The experimental animals (160–200 g) were divided into nine groups (n = 9). The blood glucose, body weight, glucose-6-phosphate dehydrogenase (G6PD), superoxide dismutase (SOD), catalase test (CAT), lipid peroxidation (TBARS), glutathione (GSH), and acetylcholinesterase (AChE) activities were determined. Oral administration of nanoparticles and T. glabra methanol extract (TGME; 10 and 15 mg/kg b.w) significantly decreased the glucose level, increased the body weight, controlled the quantitative level of G6PD, and significantly decreased the levels of ALT, ALP, cholesterol, and creatinine. Moreover, TGME and their Zn and Fe oxide nanoparticles significantly restored the antioxidant enzymes (SOD, CAT, GPx, and GSH) that decreased during induced diabetes. In the diabetic group, a significant increase in TBARS was noted and recovered in diabetic animals (p < 0.05) as compared to glibenclamide. The AChE activity was significantly recovered by nanoparticles and TGME both in the blood and brain of the diabetic group (p < 0.05). Taken together, it can be suggested that TGME and Zn and Fe oxide nanoparticles significantly improved memory and could be considered as an effective biogenic nanomaterial for diabetes, Alzheimer’s disease, and oxidative stress.

1 Introduction

Diabetes mellitus is a chronic metabolic ailment categorized by improper secretion or function of insulin, resulting in increased blood glucose levels, and several other factors such as carbohydrates, proteins, and lipids that affect metabolism and function. It is also related to hyperglycemia, which leads to oxidative stress [1]. According to the International Diabetes Federation report, the number of diabetic patients increased to above 592 million in the subsequent 25 years. Unlikely, 47% of the population is untreated and goes toward diabetic diseases ignorantly [2].

Blood contains the enzyme known as glucose-6-phosphate dehydrogenase (G6PD). Their deficiency is most frequently associated with the hexose monophosphate pathway disorder of red blood cells (RBCs) in humans. Approximately, this X-linked enzyme deficiency influences around 0.4 billion population globally [3]. In Pakistan, the occurrence of G6PD deficiency was found at about 1.8%. Various tribes of Pathans have shown a high frequency of G6PD deficiency (3.17%). Prevalence of G6PD deficiency is in Sindhis 2.77%, Punjabis 1.47%, and Kashmiris 1.07% [4]. Various extended and chronic diabetic complications, particularly in type 2 diabetes, are caused by reactive oxygen species (ROS) and an increase in free radicals. This compromises the body’s defense against antioxidant enzymes, damages cellular organelles and enzymes, and leads to problems [5]. Memory loss, neurological problems, instability in behavior, learning, planning, and daily living tasks are all symptoms of Alzheimer’s disease (AD) [6].

Neurofibrillary tangles (NFTs), senile plaques, and neuronal loss are the three major pathogenic features of AD brains [7]. A growing body of research has revealed that, in addition to the pathophysiology of senile plaques and NFT, widespread oxidative stress is a feature of AD brains. Superoxide dismutase (SOD) and catalase (CAT) are two examples of antioxidant enzymes whose activity or expression has been found to change in AD patients’ peripheral tissues as well as their central nervous system [8]. Furthermore, in AD and mild cognitive impairment brains, the enhanced oxidative loss of proteins and lipids and the decrease in glutathione and antioxidant enzyme potentials are confined to the synapses and associated with the cruelty of illness, indicating an intervention of oxidative stress in AD-related synaptic damage [9]. Aberrant levels of butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) are present in both type 2 diabetes mellitus (T2DM) and AD. AChE and BuChE levels that are altered in both AD and T2DM indicate that both of these enzymes may be crucial in the development of the two diseases. Elevated plasma concentrations of AChE and BuChE have shared characteristics with AD and T2DM [10]. Similarly, it has been discovered that diabetes patients’ AChE and BuChE activities are higher than those of normal controls [11]. This suggests that in addition to functioning as therapeutic targets, aberrant serum contents of AChE and BuChE may also serve as markers to anticipate the onset of T2DM and AD [12]. In the present study, we focused on the antidiabetic, and antioxidant effect of Zn and Fe oxide nanoparticles biofabricated by Taverniera glabra in alloxan-induced diabetic rats and to explore the beneficial effect of biofabricated nanoparticles in ameliorating neurodegeneration accompanied diabetes.

2 Materials and methods

2.1 Plant collection and authentication

A mature and fully grown-up plant of T. glabra was collected from the bank of Kurram River at Mardi Khel and Narmali Khel of District, Bannu KPK, Pakistan, while the plant Hypecoum pendulum was collected from Karak and Bannu KPK, Pakistan. The taxonomical clarification and authentication were done by Professor A. Rehman, Dept. of Taxonomy, Govt Post Graduate College Bannu, Pakistan.

2.2 Plant extract collection

After identification, washed three times with tape water and then with distilled water. After washing, shade dried for several days, and then changed into fine power by a grinder. About 2 g of ground power was heated at 40°C in a 150 mL flask for 25 min with 60 mL of distilled water, and then cooled and filtered by Whatman filter paper No. 42. The filtrate was collected and stored at 4°C for further study.

2.3 Green synthesis of nanoparticles

FeCl3·6H2O solution of 1 mM for Fe2O3 NPs and 3 mM [Zn(CH3COO)2·2H2O] solution for ZnO NPs were used as the precursor salts. By using a standard protocol, 10 mL of T. glabra extracts were put dropwise to 90 mL of respective salt solutions at pH 10 and 12.0, respectively. The mixture for Fe2O3 NPs was placed in a hotplate (60–80°C) and stirred for 8 h, while the mixture for ZnO NPs was stirred overnight. The synthesized nanoparticles were confirmed by various characterization techniques as previously published by us in Inorganic Chemistry Communications, 2022 (https://doi.org/10.1016/j.inoche.2022.110297).

2.4 Chemicals and reagents

During biological assays, analytical-grade substances such as glucometer, alloxan, Ellman’s reagent, trisodium citrate buffer, vitamin C, ethylenediaminetetraacetate, 5-methylphenazinium methyl sulfate, and methanol were utilized, which were procured from Sigma-Aldrich, Germany.

2.5 Experimental animals

This study was conducted at the University of Science and Technology Bannu, Pakistan (Ethical committee Ref. no. ustb/biotech/70). Male Wistar albino rats (160–200 g b.w.) were obtained from the animal house, National University of Science and Technology, Pakistan (NUST), and placed in cages under standard environmental conditions (25 ± 1°C; 12 h light/dark cycle). The experimental rats were fed with standard pellet food and water obtained from the NUST, Pakistan. Before starting the experiment, the rats were left for 10 days so as to adjust to the new environment.

2.6 Toxicity assay of the rats

Toxicity assay of methanolic extract of T. glabra, and their mediated ZnO NPs and Fe2O3 NPs were done against two testing and one standard animal group. The rats fasted overnight, and then different doses (15 and 30 mg/kg b.w.) of extract and NPs were orally given to the experimental groups to evaluate their toxicity. Mortality and behavioral study of the experimental animals were observed for 24 h [13] and did not observe any acute toxicity, which showed that LD50 of the NPs is greater than 30 mg/kg. Based on this experiment, further study was performed using 10 and 15 mg/kg b.w. of methanolic extract of T. glabra, and their green synthesized ZnO NPs and Fe2O3 NPs.

2.7 Diabetes induction

The diabetic condition was developed in the investigational rats with a single intraperitoneal dose of alloxan monohydrate (120 mg/kg). After 72 h of alloxan injection, blood glucose levels were determined by a glucometer. During this period 5% glucose was given instead of water to decrease death due to hyperglycemia. Rats with glucose levels higher than 200 mg/dL were selected for the experiment [14].

2.8 Experimental design

After induction of diabetes, the animals were divided into nine groups (five animals in a group) Group I: normal control, Group II: untreated diabetic rats, Group III: administrated with glibenclamide, Groups IV andV: administrated with T. glabra methanol extract 10–15 mg/kg, Groups VI and VII were treated with ZnO NPs 10, 15 mg/kg, and Groups VIII and IX administrated with Fe2O3 NPs 10, 15 mg/kg 21 days orally feeding of the glibenclamide and test samples were given every morning by 16 gauge gastric intubation [15].

2.9 In vivo assessment

2.9.1 Blood sampling and body weight examination

Tested the fasting blood glucose levels at the beginning of experimental dose administration (t = 0; first day), subsequently on days 7, 14, and 21 of the dose treatments using CGMS glucometer (US). Blood samples were collected from their tail veins. The rats were weighted regularly from day first to last (first, seventh, fourteenth, and twenty-first) [14].

2.9.2 Biochemical analysis

After 21 days of treatment, the blood samples were collected on twenty-second day, stored in EDTA tubes and centrifuged at 3,000 rpm for 10 min and the collected serum was stored at −80°C for further analysis. Alanine transaminase (ALT), alkaline phosphatase (ALP), total cholesterol, and creatinine concentrations were examined by a chemistry analyzer (Selectra, XL, Netherlands) with commercially available kits (Gesan productions, Italy) according to the manufacturer’s protocols [16].

2.9.3 AChE potential in brain and blood

AChE potential of the brain and blood were analyzed with Ellman protocol with little modifications. The reaction mixture consisted of 7.5 mL K3PO4 buffer (260 mM, pH 7.5) and 0.001 M DTNB. For starting the reactions 800 µM acetylcholine iodide was added to 100 µL of brain and serum samples. The reaction mixtures were incubated for 15 min at 25°C. Then AchE efficacy was measured at an absorbance of 412 nm. Blood serum activity was calculated from the ratio between hemoglobin level and AChE potential, and measured in µmol AcSCh/h/mg of protein [17].

2.9.4 SOD potential

SOD assays were performed by the protocol of Yadav and Yadav [18]. SOD assays were started by mixing 150 µL of blood samples, 650 µL of tetra-sodium phosphate, 0.05 µL of 5-methylphenazinium methyl sulfate, and 100 µL of reduced nicotinamide adenine dinucleotide (NAD + H). Then after 2 min, 500 µL of anhydrous acetic acid was added to break the reaction. Color strengths were calculated at 560 nm, and measured in a unit of SOD/mg protein.

2.9.5 CAT potential

CAT analysis was performed and initiated in graduated beakers by mixing 0.1 mL of blood serum samples and 0.15 mL of K3PO4 buffer (10 mM, pH 7), and then adding 0.25 mL of 160 mM hydrogen peroxide to commence the reactions. Then incubated at 97.6°F for 2 min. To break the reaction 1,000 µL of dichromate/acetic acid reagent was added. Boiled the mixture for 20 min, which changed to green color. Color strengths were calculated at 570 nm, and measured in the unit of E/min/mg protein [14].

2.9.6 Glutathione peroxidase (GSP-Px) potential

GSP-Px potentials were performed by standard Ellman’s Reagent protocol [14]. Activities were performed by combining 1,490 µL Na3PO4 buffer (400 µM, pH 7.4), 100 µL ethylenediaminetetraaceticacid (400 µM), 100 µL sodium azide (0.005 M), and 50 µL glutathione (0.004 M) mixtures were arranged. Additionally, 0.1 mL of blood samples was added to the mixture, and were incubated at 98°F for 7 min. Then 100 µL of hydrogen peroxide (0.004 M) was added to the solution and measured the glutathione at 412 nm by spectrophotometer.

2.9.7 Glutathione-S-transferase (GST) potential

GST efficacies consisted of 20 µL 0.001 M dinitrochlorobenzene [C6H3Cl(NO2)2], 2,900 µL glutathione mixture, and 0.03 mL blood samples. The glutathione mixture was organized by mixing 300 μg of glutathione in 200 mM of pH 7.5 M PO4 buffer. Changes in the yellow color of the activities were measured at 340 nm by spectrophotometer in units of GSH/mg/protein [14].

2.9.8 Lipid peroxidation assay (TBARS)

Iqbal et al. analyzed thiobarbituric acid reactive substance (TBARS) levels in lipid peroxidation assays [19]. The reaction mixture contained 100 mM pH 7.5 K3PO4 buffer (580 μL) having 200 μL blood samples, 200 μL vitamin C, and 20 μL FeCl3. The mixture was incubated at 98.6°F for 55 min and regularly shacked in a water bath. To break up the reaction 10% CCl3COOH was added. Afterward heated for 25 min and then cooled in an ice bath. After cooling centrifuged at room temperature for 12 min. Mixtures were scanned for absorbance at 535 nm wavelength.

2.9.9 Effect of G6PD in animal models

The conversion of a dye color (color changes from blue to brown) takes 30–60 min. Dye color conversion (color changes from blue to brown) takes 2–24 h.

2.9.10 Quantitative test of G6PD

The quantitative test (UV-Kinetic Method) for G6PD deficiency was accomplished by a commercially existing kit (ENZOPAK, Recon Diagnostic Pvt. Ltd). The three reagents in the kit were G6PDH-coenzyme substrate, G6PDH-buffer, G6PDH-lysing reagent. G6PD deficiency tests were performed from fresh heparinized blood.

G6PDH activity (at 30°C) = 146–376 U/1,012 RBC or 4.6–13.5 U/g Hb [20].

2.9.11 Statistical study

All data were expressed as the mean ± standard error (SEM). Statistical significance was determined using one-way analysis of variance, followed by post-hoc multiple comparisons (Tukey test) using GraphPad Prism version 8 (GraphPad Software, Inc., La Jolla, CA, USA). p ≤ 0.05 was considered to indicate a statistically significant difference.

3 Results

3.1 Acute toxicity test

A single dose of methanolic extract of T. glabra, and their mediated ZnO NPs and Fe2O3 NPs, have shown no mortality or any physical acute toxicity symptoms in treated animals during the entire experimental period. Acute toxicity assessment has presented that methanolic extract of T. glabra, and their mediated ZnO NPs and Fe2O3 NPs is safe up to 30 mg/kg body weight. So 10 mg/kg and 15 mg/kg b.w. dosages were static as adequate concentrations, and thus used in the alloxan-induced diabetic rat’s activity.

3.2 Effect of methanolic extract, and their mediated ZnO NPs and Fe2O3 NPs on blood glucose and body weight

Tables 1 and 2 illustrate blood glucose level and body weight of G6PD deficient non-diabetic control, diabetic control, methanolic extract of T. glabra-treated diabetic rats, and their mediated ZnO NPs and Fe2O3 NPs treated diabetic rats at first, seventh, fourteenth, and twenty-first, respectively. The diabetic group had considerably lower body weights (128.04 ± 2.74 vs 181.49 ± 1.08) and higher blood glucose levels as compared to the non-diabetic control group (294.76 ± 5.07 vs 91.56 ± 1.36). By oral administration of methanolic extract of T. glabra, and their mediated ZnO NPs and Fe2O3 NPs which in turn normalized blood glucose levels (Table 1) and body weight (Table 2) in the treated diabetic groups compared with non-treated diabetic groups. In every group, however, there was a considerable decrease in blood glucose level (Table 1) and an increase in the body weight (Table 2) occurred due to G6PD regulation that we experienced in samples treated diabetic rats compared with the diabetic rats.

Table 1

Effect of T. glabra methanolic extract, and their mediated ZnO NPs and Fe2O3 NPs on blood glucose in experimental animals

Parameters Blood glucose level (mg/dL)
Day 0 Day 7 Day 14 Day 21
Normal control 89.38 ± 0.79 93.27 ± 1.25 89.64 ± 1.36 91.56 ± 1.36
Diabetic control 196.67 ± 4.31 228.95 ± 3.99 269.31 ± 4.43 294.76 ± 5.07*
Glibenclamide (0.5 mg/kg) 180.19 ± 3.36 153.32 ± 2.10 129.88 ± 0.68 97.21 ± 4.66
Diabetic + METg (10 mg/kg) 192.56 ± 1.87 187.39 ± 2.58 158.09 ± 1.72 124.32 ± 2.20#
Diabetic + METg (15 mg/kg) 189.35 ± 2.34 171.01 ± 2.32 145.14 ± 1.26 109.55 ± 2.36#
Diabetic + ZnO NPs (10 mg/kg) 187.37 ± 2.35 176.24 ± 3.54 149.21 ± 1.42 105.79 ± 3.18#
Diabetic + ZnO NPs (15 mg/kg) 185.56 ± 2.47 162.21 ± 2.43 136.04 ± 1.38 102.11 ± 1.27#
Diabetic + FeO NPs (10 mg/kg) 192.01 ± 1.87 178.12 ± 2.43 152.28 ± 3.25 119.38 ± 2.45#
Diabetic + FeO NPs (15 mg/kg) 188.10 ± 1.41 164.34 ± 1.67 143.34 ± 1.23 108.23 ± 3.23#

Note: The data (n = 5) showing as mean ± SEM, showing significance at *p < 0.05: normal control vs diabetic control; # p < 0.05: diabetic control vs treated groups. METg: methanolic extract of T. glabra.

Table 2

Effect of T. glabra methanolic extract, and their mediated ZnO NPs and Fe2O3 NPs on body weight of experimental animals

Parameters Body weight variation (g)
Day 0 Day 7 Day 14 Day 21
Normal control 182.37 ± 0.92 181.71 ± 1.06 178.43 ± 0.61 181.49 ± 1.08
Diabetic control 181.58 ± 1.07 160.38 ± 1.37 145.17 ± 1.23 128.04 ± 2.74*
Glibenclamide (0.5 mg/kg) 180.11 ± 1.05 169.27 ± 1.16 170.24 ± 2.01 184.90 ± 2.16
Diabetic + METg (10 mg/kg) 181.24 ± 2.78 162.12 ± 1.22 164.41 ± 1.33 172.52 ± 1.91#
Diabetic + METg (15 mg/kg) 180.23 ± 2.64 167.57 ± 2.55 170.29 ± 1.83 178.58 ± 2.68#
Diabetic + ZnO NPs (10 mg/kg) 179.54 ± 3.63 164.08 ± 2.27 166.95 ± 2.82 174.19 ± 3.17#
Diabetic + ZnO NPs (15 mg/kg) 180.33 ± 4.32 165.31 ± 1.54 171.58 ± 3.17 180.52 ± 1.22#
Diabetic + Fe2O3 NPs (10 mg/kg) 178.56 ± 2.27 152.12 ± 2.53 160.17 ± 1.45 172.04 ± 1.47#
Diabetic + Fe2O3 NPs (15 mg/kg) 180.16 ± 2.42 157.08 ± 2.19 164.34 ± 2.18 175.31 ± 3.27#

Note: The data (n = 5) showing as mean ± SEM, showing significance at *p < 0.05: normal control vs diabetic control; # p < 0.05: diabetic control vs treated groups. METg: methanolic extract of T. glabra.

3.3 Effect of T. glabra methanolic extract, and their mediated ZnO NPs and Fe2O3 NPs on biochemical parameters

When diabetic rats were compared to non-diabetic controls, the G6PD level was significantly decreased (p < 0.05) (Table 3). As G6PD levels decreased, diabetic rats also had significantly (p < 0.05) higher levels of ALT (86 ± 5.3 IU/L vs 32 ± 2.9 IU/L), ALP (263 ± 5.7 IU/L vs 118 ± 2.9 IU/L), cholesterol (107.64 ± 5.7 mg/dL vs 39.65 ± 5.8 mg/dL), and creatinine (1.78 0.11 mg/dL vs 0.54 ± 0.08 mg/dL). The lack of G6PD enzyme in diabetic rats was sustained by glibenclamide, a methanolic extract of T. glabra, and its mediated ZnO NPs and Fe2O3 NPs treatments. The change in ALT, ALP, cholesterol, and creatinine (Table 3) in diabetic rats likewise returned to normal as the G6PD deficit stabilized. It was hypothesized that nanoparticles and T. glabra methanolic extract administration could regulate blood parameters and stabilize the G6PD enzyme as a result of the significant reduction (p < 0.05) in G6PD level in diabetic rats (Table 3).

Table 3

Effect of T. glabra methanolic extract, and their mediated ZnO NPs and Fe2O3 NPs on G6PD, ALT, ALP, creatinine, and cholesterol on diabetic rats

Parameters G6PD (min) ALT (IU/L) ALP (IU/L) Creatinine (mg/dL) Cholesterol (mg/dL)
Normal control 25.63 ± 0.56 32 ± 2.9 118 ± 2.9 0.54 ± 0.08 39.65 ± 5.8
Diabetic control >9* 86 ± 5.3* 263 ± 5.7* 1.78 ± 0.11* 107.64 ± 5.7*
Glibenclamide (0.5 mg/kg) 31.26 ± 0.52 39 ± 4.5 126 ± 4.6 0.62 ± 0.07 45.29 ± 4.9
Diabetic + METg (10 mg/kg) 49.33 ± 0.76# 68 ± 5.8# 173 ± 4.8# 1.09 ± 0.05# 91.64 ± 5.3#
Diabetic + METg (15 mg/kg) 44.05 ± 0.35# 45 ± 4.6# 140 ± 5.3# 0.81 ± 0.04# 59.21 ± 5.1#
Diabetic + ZnO NPs (10 mg/kg) 39.19 ± 0.28# 61 ± 3.5# 162 ± 5.7# 1.04 ± 0.05# 86.02 ± 4.9#
Diabetic + ZnO PNs (15 mg/kg) 30.42 ± 0.40# 42 ± 5.8# 134 ± 4.5# 0.79 ± 0.03# 53.07 ± 5.2#
Diabetic + Fe2O3 NPs (10 mg/kg) 53.83 ± 1.06# 65 ± 5.7# 179 ± 5.8# 1.25 ± 0.14# 92.66 ± 5.8#
Diabetic + Fe2O3 NPs (15 mg/kg) 48.35 ± 1.15# 48 ± 6.2# 145 ± 5.9# 0.86 ± 0.09# 59.93 ± 5.4#

Note: The data (n = 5) showing as mean ± SEM, showing significance at *p < 0.05: normal control vs diabetic control; # p < 0.05: diabetic control vs treated groups. METg: methanolic extract of T. glabra.

3.4 Effect of methanolic extract of T. glabra, and their mediated ZnO NPs and Fe2O3 NPs on antioxidant enzymes

Results found that the concentrations of antioxidant enzymes such as SOD, CAT, GPx, and GSH were significantly decreased, while TBARS concentration was increased in diabetic rats as compared to non-diabetic rats (Figure 1). In G6PD deficient, a significant decrease (p < 0.05) in SOD (8.36 ± 0.91 vs 8.36 ± 0.91) SOD/mg of protein, CAT (3.37 ± 2.8 vs 7.45 ± 3.2) E/min/mg of protein, GPx (3.79 ± 1.3 vs 9.01 ± 3.5) nmol/NADPH/min/mg of protein, and GSH (44.56 ± 5.9 vs 98.74 ± 7.6) GSH/mg of protein were examined in diabetic rats, while the increase in TBARS level (3.67 ± 0.11 vs 1.84 ± 0.08) nmol MDA/mg of protein were observed. The deficits in antioxidant indicators, such as SOD, CAT, GPx, GSH, and TBARS elevations, as shown in Figure 1, were corrected by oral administration of T. glabra extract and their mediated zinc and iron oxide nanoparticles (10 and 15 mg/kg).

Figure 1 
                  Effect of T. glabra methanolic extract and their mediated ZnO NPs and Fe2O3 NPs on the TBARS and SOD, CAT, GPx, and GSH enzyme activities in diabetic rats. *p < 0.05: normal control vs diabetic control; #p < 0.05: diabetic control vs treated groups. METg: methanolic extract of T. glabra.
Figure 1

Effect of T. glabra methanolic extract and their mediated ZnO NPs and Fe2O3 NPs on the TBARS and SOD, CAT, GPx, and GSH enzyme activities in diabetic rats. *p < 0.05: normal control vs diabetic control; #p < 0.05: diabetic control vs treated groups. METg: methanolic extract of T. glabra.

3.5 Effect of methanolic extract of T. glabra, and their mediated ZnO NPs and Fe2O3 NPs on AChE potential in different brain portions and blood of diabetic rats

Results showed that the AChE level in the homogenate of the brain was significantly (p < 0.05) higher in diabetic rats as compared to normal healthy rats. The AChE potential was significantly (p < 0.05) reduced in the rats which were given methanolic extracts of T. glabra and their mediated zinc and iron oxide nanoparticles (10 and 15 mg/kg body weight, respectively) in the cerebral cortex, cerebellum, hypothalamus, striatum, and hippocampus (Table 4). Additionally, it was discovered that diabetic rats’ blood levels of the AChE enzyme were significantly higher (p < 0.05) than those of normal healthy rats. At the end of the trial (21 days), the treatment of methanolic extracts of T. glabra, ZnO NPs, and Fe2O3 NPs (10 and 15 mg/kg b.w.) considerably reduced the increased concentrations of AChE in the blood of diabetic rats (Figure 2).

Table 4

Effect of T. glabra methanolic extract and their mediated ZnO NPs and Fe2O3 NPs on AChE potential in different brain portions of diabetic rats

Parameters Cerebral cortex Cerebellum Hypothalamus Striatum Hippocampus
Normal control 54.7 ± 2.16 48.23 ± 2.34 44.8 ± 4.51 41.3 ± 3.7 40.53 ± 5.14
Diabetic control 83.5 ± 5.23* 76.14 ± 3.43* 73.9 ± 5.43* 71.5 ± 4.5* 72.15 ± 5.12*
Glibenclamide (0.5 mg/kg) 57.9 ± 3.05 52.32 ± 2.37 47.5 ± 3.80 43.2 ± 3.4 43.27 ± 5.09
Diabetic + METg (10 mg/kg) 81.4 ± 5.21# 74.21 ± 3.51# 71.6 ± 5.54# 70.4 ± 5.5# 70.53 ± 7.10#
Diabetic + ME Tg (15 mg/kg) 68.5 ± 4.37# 63.42 ± 3.23# 61.2 ± 4.32# 59.5 ± 4.6# 58.45 ± 7.24#
Diabetic + ZnO NPs (10 mg/kg) 74.4 ± 5.12# 69.35 ± 4.13# 64.4 ± 5.01# 61.7 ± 4.3# 62.57 ± 5.43#
Diabetic + ZnO NPs (15 mg/kg) 61.9 ± 4.05# 54.26 ± 3.17# 48.5 ± 3.25# 46.9 ± 4.4# 45.62 ± 5.21#
Diabetic + FeO NPs (10 mg/kg) 76.5 ± 5.23# 71.63 ± 3.51# 68.3 ± 5.30# 66.5 ± 5.3# 68.33 ± 6.29#
Diabetic + FeO NPs (15 mg/kg) 62.3 ± 5.10# 58.52 ± 3.46# 56.1 ± 4.17# 53.4 ± 4.5# 51.07 ± 5.67#

Note: The data (n = 5) showing as mean ± SEM, showing significance at *p < 0.05: normal control vs diabetic control; # p < 0.05: diabetic control vs treated groups. METg: methanolic extract of T. glabra, measuring unit = µmol AcSCh/h/mg of protein.

Figure 2 
                  Effect of T. glabra methanolic extract and their mediated ZnO NPs and Fe2O3 NPs on AChE activity in the blood of diabetic rats. The data (n = 5) showing as mean ± SEM, showing significance at *p < 0.05: normal control vs diabetic control; #
                     p < 0.05: diabetic control vs treated groups. METg (methanolic extract of T. glabra).
Figure 2

Effect of T. glabra methanolic extract and their mediated ZnO NPs and Fe2O3 NPs on AChE activity in the blood of diabetic rats. The data (n = 5) showing as mean ± SEM, showing significance at *p < 0.05: normal control vs diabetic control; # p < 0.05: diabetic control vs treated groups. METg (methanolic extract of T. glabra).

4 Discussion

In the current study, we show that alloxan-induced diabetic rats had hyperglycemia, lower body weights, elevated liver functions, creatinine, cholesterol, and oxidative stress, as well as lower levels of G6PD and antioxidant enzymes and significantly higher AChE activity in the blood and various brain regions. The pathophysiology of diabetic neuropathy is one that is rapidly expanding and should be of worldwide concern. In most situations, diabetic neuropathy begins as a modest, serum glucose-dependent fiber neuropathy. Discovering novel substances and treatment approaches to reduce the hazards associated with diabetes is of great interest. As a result, in the current study, we investigated the neuroprotective and ameliorative potential of Zn and Fe oxide nanoparticles biofabricated by T. glabra in rats with alloxan-induced diabetes. The acute toxicity assay did not show any toxic behavior of methanol extract and biochemically synthesized ZnO NPs and Fe2O3 NPs. The alloxan-induced diabetic rats administrated with different concentrations of T. glabra methanolic extract, and their mediated ZnO NPs and Fe2O3 NPs, have not exposed any physical mark of harmfulness in the entire experiment, and no deaths were observed. Based on this study, with different doses of methanol extract, ZnO NPs and Fe2O3 NPs, 10 and 15 mg/kg body weights were taken as a suitable dose, and so used for administration of alloxan-treated animals.

The blood glucose levels have been observed in the whole treatment, to assess the effect on G6PD and the anti-diabetic effect of methanolic extract and green synthesized nanoparticles (ZnO NPs, Fe2O3 NPs). At the end of the experiment (twenty-first day) the administrated groups (extract and NPs) noticeably stabilized G6PD and reduced the blood glucose concentration compared to diabetic control (Group II). It was reported that the activity of G6PD in animal studies was enhanced when treated with zinc, as it takes part in the activation of zinc enzymes [21]. ZnO NPs have revealed low blood glucose level compared to Fe2O3 NPs and plant extract. On the other hand, glibenclamide stabilized G6PD considerably and so decreased the blood glucose level in the whole period of administration compared to other groups.

Alloxan-induced diabetic animal studies have been generally used in numerous studies, and the way of action of alloxan is healthy and accepted [22,23]. In the treatment of diabetes, the blood glucose level is considered a main biochemical marker to observe the progress in the disease disorder [23]. Table 2 shows the variations in body weight of investigational rats, before and after dose administration. Body weight loss is the main sign related with diabetes, possibly due to muscle wasting [24]. In our study the alloxan-induced diabetic rats group (Group II) showed significant weight loss (Table 2) compared normal control (Group I). The ALT, ALP, creatinine, and total cholesterol levels were also high in diabetic rats (Table 3).

It was reported that diabetes mellitus decreased the body weight due to increased muscle deteriorating, dehydration, and fat catabolism. Whereas, G6PD treated by plant extract and nanoparticles significantly increased the body weight loss. The ALT, ALP, creatinine, and total cholesterol levels were also recovered in diabetic rats over a period of 21 days treatment (Table 3). The mechanism of inhibiting the muscle loss could possibly attribute to the reverse of antagonism [25].

Research presented that elevated glucose levels leads to enhanced oxidative stress in diabetic rats and patients [26]. Too much evidence are present for increased oxidative stress in diabetic problems. Research has shown that cultured cells allowed high glucose to have high oxidative stress as found by higher levels of lipid peroxidation and high level of ROS [26,27]. Another researcher cultured cells and administrated to high levels of antioxidants (GSH, SOD, or CAT) are defensive against harmful effects of high glucose level. Similarly, ROS species have been presented that these may be either the cause or may be a concern with the path that have presented to facilitate diabetic disorders, such as aldose reductase activity showed exhaustion of NADPH, and as a result ROS species are increased [27]. Thus these evidence showed that high oxidative stress is the main cause of diabetic mellitus disorders.

Anti-oxidative system is preserved and maintained by adequate production of reductants like NADPH. As NADPH is the main cofactor of CAT enzyme as it retains the enzyme in active form. NADPH is also the cofactor of glutathione reductase, which is a free radical scavenger. As the main source of NADPH, the function of G6PD as an antioxidant enzyme has been currently healthily particularized. It was presented that G6PD-null cells have better sensitivity against oxidative stress [28]. Furthermore, G6PD supports the protection of oxidative stress-created apoptosis [29]. It was reported that elevated glucose levels in cultured endothelial cells inhibited the activity of G6PD [30]. D’Alessandro et al. presented that G6PD activity was greatly inhibited and decreased in both glomeruli and tubules of the kidney of diabetic mice compared with normal control [31]. Data from the current study proposed that G6PD activity of the liver and kidney in diabetic animals was inhibited through elevated blood glucose levels compared to normal control. This study is reliable with the previous available studies in which deficiency of G6PD activities have been reported in the liver, aorta, and heart cells from diabetic animal modules [31,32]. Diabetic patients possess reduced G6PD levels in the liver. Hemolysis of blood cells created G6PD deficiency in diabetes mellitus patients, particularly in newborns were also reported [33].

Systematic observations of G6PD activity of some people suggested an enhanced occurrence of G6PD deficiency in people with diabetes, as compared to normal people [34]. So many studies are performed about the association between G6PD deficiency and diabetes mellitus and has been a matter of debate. The hypothesis revealed that G6PD deficiency is related to hyperglycemia and diabetic conditions are increased [35]. In contrast to other studies, Salomon et al. revealed no noteable changes in G6PD deficiency offspring compared to G6PD control, presenting the lack of diabetes in the newborns. In G6PD deficient newborns serum bilirubin, AST, and ALT levels were found higher than in G6PD control [36]. The hypothesis of liver malfunctions and damage is reported to have a high quantity of cholesterol and ALT in several G6PD deficient patients [37].

Diabetes mellitus is well-documented for its capacity to cause oxidative stress in a variety of tissues. A significant extent of superoxide and supplementary free radicals are released in the cytoplasm, because of the increased mitochondrial glucose oxidation brought on by hyperglycemia. Recent research stated that the production of advanced glycation end products, due to which superoxide formation takes place, is caused by chronic hyperglycemia. As a result, NADPH oxidase is activated, increasing the production of superoxide. The escalation of MDA concentrations while the decline in SOD and GSH activity of cells were indicators of an oxidative stress state brought on by diabetes [38].

The influence of methanolic extract, zinc oxide, and iron oxide nanoparticles on lipid peroxidation (MDA), SOD, CAT, GPx, and GSH, our findings presented that there is a significant decrease in the concentrations of SOD, CAT, GPx, and GSH, while an increase in the concentration of MDA in the blood of diabetic animals. In contrast to these methanolic extracts, zinc oxide and iron oxide nanoparticles increase SOD, CAT, GPx, and GSH, while decreasing the level of MDA, decreases an essential element in different antioxidant enzymes such as Zn-SOD, Zn-metallothionein, etc. [39]. Several researchers examined that Zn-metallothionein along with islet cells gives defense against various free radicles that originated in the body originating sources and causes. The cell’s potential to defend itself from this oxide itself uses as intracellular Zn levels get more depleted. This is a hypothetical mechanism by which a zinc deficiency shows how rapidly diabetes mellitus develops. Gupta et al. examined the lipid peroxide levels in the nervous system of animals nourished by nutrition low in zinc and discovered that SOD levels were decreased in the cerebrum, cerebellum, hypothalamus, hippocampus, brainstem, while peroxide levels increased in several areas of the brain and spinal cord [40].

According to Aruoma, Cu, Zn, and Mn are essential elements for the potentials of the respective SOD enzymes (Cu, Zn-SOD, and Mn-SOD). Therefore, tissue Cu, Zn-SOD, and Mn-SOD potentials are significantly decreased when these minerals are deficient in the diet, which causes peroxidative impairment and mitochondrial dysfunction [41]. In diabetic rat brain tissue, we demonstrated ZnO NPs’ antioxidant properties. In the treated diabetic rats’ brain cells, it raised the assay and messenger ribonucleic acid (mRNA) manifestation concentrations of SOD, GSP-Px, CAT, and glutathione reductase concentrations while decreasing MDA levels [42]. According to Pantic et al., diabetic animals’ oxidative stress is reduced by ZnO NPs and silver nanoparticles. Fifty male albino rats, which are frequently used as diabetes experimentation models, were used in the study. By raising their activity and mRNA expression levels, the authors claimed that ZnO NPs have beneficial effects on SOD, GPx, CAT, and GSH [43]. ZnO NPs were identified as potential antidiabetic drugs. They cause the production of more insulin and lowering blood sugar and also has a suppressant effect on the oxidation of fats and proteins [44].

Similarly, Ebrahimpour et al. found that oral administration of superparamagnetic iron between 30 and 50 nm significantly improved memory function in diabetic rats, and they suggested a successful combination therapy for the maintenance of learning and memory [45]. Another researcher Ebrahimpour et al. validated the antioxidant activity of quercetin in numerous ailments, which share oxidative stress by restoring histological abnormalities with quercetin and quercetin-conjugated superparamagnetic iron treatments. Additionally, QC and iron oxide nanoparticles are harmless antioxidant substances whenever given in substances less than 0.5 g two-fold per day for 2.76 months in people, according to several human studies [46].

5 Conclusion

The present research project proposes that the T. glabra methanolic extract and their mediated ZnO NP and Fe2O3 NP have significant effect on oxidative stress and G6PD, which in turn regulate ALT, ALP, creatinine, and cholesterol levels in diabetic conditions. Finally, it is concluded that the extract of T. glabra methanolic extract and their mediated ZnO NP and Fe2O3 NP are valuable source of neuroprotective, antioxidative, and antidiabetic candidates with special reference to ameliorate one of the most complications of diabetes (diabetic neuropathy). Further analysis is required regarding its pharmaceutical and therapeutic potentials.


# All authors have contributed equally.


  1. Funding information: The authors extend their appreciation to the Researchers Supporting Project number (RSPD2023R758), King Saud University, Riyadh, Saudi Arabia.

  2. Author contributions: All authors participated in the design and interpretation of studies, the analysis of the data, and the review of the manuscript. Aziz Ullah Khan, Hidayat Ullah Khan, Fahim Ullah Khan, and Fozia Fozia conducted the experiments and collected the data, Shahnaz Khan, Naveed Kamran, and Ijaz Ahmad were responsible for the analysis and mapping of the data. Mohamed Mohany provided methodological and technical guidance. Mourad A.M. Aboul-Soud wrote the manuscript, and Nouf S.S. Zaghloul, Salim S. Al-Rejaie, and Mohamed Mohany project administration, edited, and reviewed the manuscript. All authors read and approved the final manuscript.

  3. Conflict of interest: The authors declared no conflict of interest.

  4. Ethical approval: The research related to animals’ use has been complied with all the relevant national regulations and institutional policies for the care and use of animals.

  5. Data availability statement: All data generated or analyzed during this work are included in this published article. Also, all data used to support the findings of this study are available from the corresponding author upon request.

References

[1] Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12(4):542.10.3390/biom12040542Search in Google Scholar PubMed PubMed Central

[2] Pop D, Gheldiu AM, Oroian M, Marcovici A, Bhardwaj S, Khuroo A, et al. Effect of food on the pharmacokinetics of gliclazide 60 mg modified release tablet in healthy Caucasian volunteers. Acta Marisiensis-Seria Medica. 2018;64(4):161–8.10.2478/amma-2018-0022Search in Google Scholar

[3] Alakbaree M, Amran S, Shamsir M, Ahmed HH, Hamza M, Alonazi M, et al. Human G6PD variant structural studies: elucidating the molecular basis of human G6PD deficiency. Gene Rep. 2022;101634. 10.1016/j.genrep.2022.101634.Search in Google Scholar

[4] Moiz B, Arshad HM, Raheem A, Hayat H, Karim Ghanchi N, Beg MA. Frequency of G6PD mediterranean in individuals with and without malaria in Southern Pakistan. Malar J. 2017;16(1):1–6.10.1186/s12936-017-2069-4Search in Google Scholar PubMed PubMed Central

[5] Kang GG, Francis N, Hill R, Waters D, Blanchard C, Santhakumar AB. Dietary polyphenols and gene expression in molecular pathways associated with type 2 diabetes mellitus: a review. Int J Mol Sci. 2019;21(1):140.10.3390/ijms21010140Search in Google Scholar PubMed PubMed Central

[6] García-González L, Pilat D, Baranger K, Rivera S. Emerging alternative proteinases in APP metabolism and Alzheimer’s disease pathogenesis: a focus on MT1-MMP and MT5-MMP. Front Aging Neurosci. 2019;11:244.10.3389/fnagi.2019.00244Search in Google Scholar PubMed PubMed Central

[7] Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010;362:329–44. 10.1056/NEJMra0909142.Search in Google Scholar PubMed

[8] Praticò D. Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal. Trends Pharmacol Sci. 2008;29(12):609–15.10.1016/j.tips.2008.09.001Search in Google Scholar PubMed

[9] Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease. Neurosci Lett. 2010;469(1):6–10.10.1016/j.neulet.2009.11.033Search in Google Scholar PubMed

[10] Ansari MA, Scheff SW. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol. 2010;69(2):155–67.10.1097/NEN.0b013e3181cb5af4Search in Google Scholar PubMed PubMed Central

[11] Reale M, Nicola MD, Velluto L, D’Angelo C, Costantini E, Lahiri DK, et al. Selective acetyl-and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer’s disease subjects: exploring the cholinergic anti-inflammatory pathway. Curr Alzheimer Res. 2014;11(6):608–22.10.2174/1567205010666131212113218Search in Google Scholar PubMed PubMed Central

[12] Mushtaq G, A Khan J, A Kamal M. Biological mechanisms linking Alzheimer’s disease and type-2 diabetes mellitus. CNS Neurol Disord-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2014;13(7):1192–201.10.2174/1871527313666140917114537Search in Google Scholar PubMed

[13] Sengottaiyan A, Aravinthan A, Sudhakar C, Selvam K, Srinivasan P, Govarthanan M, et al. Synthesis and characterization of Solanum nigrum-mediated silver nanoparticles and its protective effect on alloxan-induced diabetic rats. J Nanostruct Chem. 2016;6(1):41–8.10.1007/s40097-015-0178-6Search in Google Scholar

[14] Shah MAR, Khan RA, Ahmed M. Sorghum halepense (L.) Pers rhizomes inhibitory potential against diabetes and free radicals. Clin Phytoscience. 2021;7(1):1–16.10.1186/s40816-021-00259-3Search in Google Scholar

[15] Sekineh P, Dehkordi SH, Karimi B. The combinatory effects of zinc oxide nanoparticles (ZnO NPs) and thiamine on skin of alloxan-induced diabetic mice; a stereological and biochemical study. 2022. 10.21203/rs.3.rs-1228507/v1.Search in Google Scholar

[16] Liu L, Yasen M, Tang D, Ye J, Aisa HA, Xin X. Polyphenol-enriched extract of Rosa rugosa Thunb regulates lip rugosa Thunbsm in diabetic rats by activation of AMPK pathway. Biomed Pharmacother. 2018;100:29–35.10.1016/j.biopha.2018.01.143Search in Google Scholar PubMed

[17] Hritcu L, Bagci E, Aydin E, Mihasan M. Antiamnesic and antioxidants effects of Ferulago angulata essential oil against scopolamine-induced memory impairment in laboratory rats. Neurochem Res. 2015;40(9):1799–809.10.1007/s11064-015-1662-6Search in Google Scholar PubMed

[18] Yadav E, Yadav P. Biofabricated zinc oxide nanoparticles impair cognitive function via modulating oxidative stress and acetylcholinesterase level in mice. Environ Toxicol. 2021;36(4):572–85.10.1002/tox.23062Search in Google Scholar PubMed

[19] Iqbal M, Sharma SD, Rezazadeh H, Hasan N, Abdulla M, Athar MJRR. Glutathione metabolizing enzymes and oxidative stress in ferric nitrilotriacetate mediated hepatic injury. Redox Rep. 1996;2(6):385–91.10.1080/13510002.1996.11747079Search in Google Scholar PubMed

[20] Sahal S, Ghosh R, Mukherjee K. G6PD deficiency: prevalence and effect on BC parameters in a teron RBC care center in Southern Bengal center MPR. Int J Curr Med Pharm Res. 2017;3(9):2329–32.Search in Google Scholar

[21] Fırat Ö, Kargın F. Effects of zinc and cadmium on erythrocyte antioxidant systems of a freshwater fish Oreochromis niloticus. J Biochem Mol Toxicol. 2010;24(4):223–9.10.1002/jbt.20327Search in Google Scholar PubMed

[22] Attanayake AP, Jayatilaka KA, Pathirana C, Mudduwa LK. Study of antihyperglycaemic activity of medicinal plant extracts in alloxan-induced diabetic rats. Anc Sci Life. 2013;32(4):193.10.4103/0257-7941.131970Search in Google Scholar PubMed PubMed Central

[23] Wang Y, Yang P, Yan Z, Liu Z, Ma Q, Zhang Z, et al. The relationship between erythrocytes and diabetes mellitus. J Diabetes Res. 2021;2021:6656062. 10.1155/2021/6656062.Search in Google Scholar PubMed PubMed Central

[24] Shiekuma S, Ukeyima M, Msendoo JA, Blessing I, Tughgba T. Effect of sorghum-tigernut ibyer (a traditional gruel) on the fasting blood glucose levels of alloxan-induced diabetic rats. Eur J Nutr Food Saf. 2019;29:260–8.10.9734/ejnfs/2019/v9i330065Search in Google Scholar

[25] Khan ST, Ahmed M, Khan RA, Mushtaq N, Khan N. The anti-diabetic potential of aerial parts of Galium tricornutum (Dandy) Rubiaceae. Trop J Pharm Res. 2017;16(7):1573–8.10.4314/tjpr.v16i7.15Search in Google Scholar

[26] Cecilia OM, José Alberto CG, José NP, Ernesto Germán CM, Ana Karen LC, Luis Miguel RP, et al. Oxidative stress is the main target in diabetic retinopathy pathophysiology. J Diabetes Res. 2019;2019:8562408. 10.1155/2019/8562408.Search in Google Scholar PubMed PubMed Central

[27] Zhang P, Li T, Wu X, Nice EC, Huang C, Zhang Y. Oxidative stress and diabetes: antioxidative strategies. Front Med. 2020;14(5):583–600.10.1007/s11684-019-0729-1Search in Google Scholar PubMed

[28] Ge T, Yang J, Zhou S, Wang Y, Li Y, Tong X. The role of the pentose phosphate pathway in diabetes and cancer. Front Endocrinol. 2020;11:365.10.3389/fendo.2020.00365Search in Google Scholar PubMed PubMed Central

[29] Yang HC, Wu YH, Yen WC, Liu HY, Hwang TL, Stern A, et al. The redox role of G6PD in cell growth, cell death, and cancer. Cells. 2019;8(9):1055.10.3390/cells8091055Search in Google Scholar PubMed PubMed Central

[30] Vanessa Fiorentino T, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus-related cardiovascular diseases. Curr Pharm Des. 2013;19(32):5695–703.10.2174/1381612811319320005Search in Google Scholar PubMed

[31] D’Alessandro A, Howie HL, Hay AM, Dziewulska KH, Brown BC, Wither MJ, et al. Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice. JCI Insight. 2021;6(14):e147056. 10.1172/jci.insight.147056.Search in Google Scholar PubMed PubMed Central

[32] Spencer NY, Stanton RC. Glucose 6-phosphate dehydrogenase and the kidney. Curr Op Nephrol Hypertens. 2017;26(1):43–9.10.1097/MNH.0000000000000294Search in Google Scholar PubMed

[33] Xu A, Jiang M, Zhang W, Lin Y, Shao Y, Mei H, et al. Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in a cohort of new-onset type 1 diabetes children in Guangdong province. China Diabetol Metab Syndrome. 2022;14(1):1–8.10.1186/s13098-022-00812-1Search in Google Scholar PubMed PubMed Central

[34] Karadsheh NS, Quttaineh NA, Karadsheh SN, El-Khateeb M. Effect of combined G6PD deficiency and diabetes on protein oxidation and lipid peroxidation. BMC Endocr Disord. 2021;21(1):1–5.10.1186/s12902-021-00911-6Search in Google Scholar PubMed PubMed Central

[35] Ulusu NN, Sahilli M, Avci A, Canbolat O, Ozansoy G, Ari N, et al. Pentose phosphate pathway, glutathione-dependent enzymes, and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Neurochem Res. 2003;28(6):815–23.10.1023/A:1023202805255Search in Google Scholar PubMed

[36] Salomon FFM, Casimir AD, Segbo AG, Julien SAG, Gilles B, Marc MTC, et al. Liver function assessment in Glucose-6-phosphate dehydrogenase deficient neonates in Benin. Int J Biomed Res. 2018;9(6):221–5.Search in Google Scholar

[37] Çelik R, Mert H, Comba B, Mert N. Effects of cinnamaldehyde on glucose-6-phosphate dehydrogenase activity, some biochemical and hematological parameters in diabetic rats. Biomarkers. 2022;27(3):270–7.10.1080/1354750X.2022.2032351Search in Google Scholar PubMed

[38] Afifi M, Almaghrabi OA, Kadasa NM. Ameliorative effect of zinc oxide nanoparticles on antioxidants and sperm characteristics in streptozotocin-induced diabetic rat testes. BioMed Res Int. 2015;2015:153573. 10.1155/2015/153573.Search in Google Scholar PubMed PubMed Central

[39] Arthur BC, Chausmer S. Zinc, insulin, and diabetes. J Am Coll Nutr. 1998;17(2):109–15.10.1080/07315724.1998.10718735Search in Google Scholar PubMed

[40] Gupta R, Garg VK, Mathur DK, Goyal RK. Oral zinc therapy in diabetic neuropathy. J Assoc Physicians India. 1998;46(11):939–42.Search in Google Scholar

[41] Aruoma OI. Free radicals, oxidative stress, and antioxidants in human health and disease. J Am Oil Chemists’ Soc. 1998;75(2):199–212.10.1007/s11746-998-0032-9Search in Google Scholar PubMed PubMed Central

[42] Afifi M, Abdelazim AM. Ameliorative effect of zinc oxide and silver nanoparticles on antioxidant system in the brain of diabetic rats. Asian Pac J Trop Biomed. 2015;5(10):874–7.10.1016/j.apjtb.2015.06.010Search in Google Scholar

[43] Pantic S, Skodric SR, Loncar Z, Pantic I. Zinc oxide nanoparticles: potential novel applications in cellular physiology, pathology, neurosciences, and cancer research. Rev Adv Mater Sci. 2019;58(1):17–21.10.1515/rams-2019-0002Search in Google Scholar

[44] Wapnerpnir RA. Zinc deficiency, malnutrition, and the gastrointestinal tract. J Nutr. 2000;130(5):1388S–92S.10.1093/jn/130.5.1388SSearch in Google Scholar PubMed

[45] Ebrahimpour S, Esmaeili A, Beheshti S. Effect of quercetin-conjugated superparamagnetic iron oxide nanoparticles on diabetes-induced learning and memory impairment in rats. Int J Nanomed. 2018;13:6311.10.2147/IJN.S177871Search in Google Scholar PubMed PubMed Central

[46] Ebrahimpour S, Shahidi SB, Abbasi M, Tavakoli Z, Esmaeili A. Quercetin-conjugated superparamagnetic iron oxide nanoparticles (QCSPIONs) increases Nrf2 expression via miR-27a mediation to prevent memory dysfunction in diabetic rats. Sci Rep. 2020;10(1):1–12.10.1038/s41598-020-71971-2Search in Google Scholar PubMed PubMed Central

Received: 2023-02-12
Accepted: 2023-02-24
Published Online: 2023-03-13

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Characteristics, source, and health risk assessment of aerosol polyaromatic hydrocarbons in the rural and urban regions of western Saudi Arabia
  2. Regular Articles
  3. A network-based correlation research between element electronegativity and node importance
  4. Pomegranate attenuates kidney injury in cyclosporine-induced nephrotoxicity in rats by suppressing oxidative stress
  5. Ab initio study of fundamental properties of XInO3 (X = K, Rb, Cs) perovskites
  6. Responses of feldspathic sandstone and sand-reconstituted soil C and N to freeze–thaw cycles
  7. Robust fractional control based on high gain observers design (RNFC) for a Spirulina maxima culture interfaced with an advanced oxidation process
  8. Study on arsenic speciation and redistribution mechanism in Lonicera japonica plants via synchrotron techniques
  9. Optimization of machining Nilo 36 superalloy parameters in turning operation
  10. Vacuum impregnation pre-treatment: A novel method for incorporating mono- and divalent cations into potato strips to reduce the acrylamide formation in French fries
  11. Characterization of effective constituents in Acanthopanax senticosus fruit for blood deficiency syndrome based on the chinmedomics strategy
  12. Comparative analysis of the metabolites in Pinellia ternata from two producing regions using ultra-high-performance liquid chromatography–electrospray ionization–tandem mass spectrometry
  13. The assessment of environmental parameter along the desalination plants in the Kingdom of Saudi Arabia
  14. Effects of harpin and carbendazim on antioxidant accumulation in young jujube leaves
  15. The effects of in ovo injected with sodium borate on hatching performance and small intestine morphology in broiler chicks
  16. Optimization of cutting forces and surface roughness via ANOVA and grey relational analysis in machining of In718
  17. Essential oils of Origanum compactum Benth: Chemical characterization, in vitro, in silico, antioxidant, and antibacterial activities
  18. Translocation of tungsten(vi) oxide/gadolinium(iii) fluoride in tellurite glasses towards improvement of gamma-ray attenuation features in high-density glass shields
  19. Mechanical properties, elastic moduli, and gamma ray attenuation competencies of some TeO2–WO3–GdF3 glasses: Tailoring WO3–GdF3 substitution toward optimum behavioral state range
  20. Comparison between the CIDR or sponge with hormone injection to induce estrus synchronization for twining and sex preselection in Naimi sheep
  21. Exergetic performance analyses of three different cogeneration plants
  22. Psoralea corylifolia (babchi) seeds enhance proliferation of normal human cultured melanocytes: GC–MS profiling and biological investigation
  23. A novel electrochemical micro-titration method for quantitative evaluation of the DPPH free radical scavenging capacity of caffeic acid
  24. Comparative study between supported bimetallic catalysts for nitrate remediation in water
  25. Persicaline, an alkaloid from Salvadora persica, inhibits proliferation and induces apoptosis and cell-cycle arrest in MCF-7 cells
  26. Determination of nicotine content in locally produced smokeless tobacco (Shammah) samples from Jazan region of Saudi Arabia using a convenient HPLC-MS/MS method
  27. Changes in oxidative stress markers in pediatric burn injury over a 1-week period
  28. Integrated geophysical techniques applied for petroleum basins structural characterization in the central part of the Western Desert, Egypt
  29. The impact of chemical modifications on gamma-ray attenuation properties of some WO3-reinforced tellurite glasses
  30. Microwave and Cs+-assisted chemo selective reaction protocol for synthesizing 2-styryl quinoline biorelevant molecules
  31. Structural, physical, and radiation absorption properties of a significant nuclear power plant component: A comparison between REX-734 and 316L SS austenitic stainless steels
  32. Effect of Moringa oleifera on serum YKL-40 level: In vivo rat periodontitis model
  33. Investigating the impact of CO2 emissions on the COVID-19 pandemic by generalized linear mixed model approach with inverse Gaussian and gamma distributions
  34. Influence of WO3 content on gamma rays attenuation characteristics of phosphate glasses at low energy range
  35. Study on CO2 absorption performance of ternary DES formed based on DEA as promoting factor
  36. Performance analyses of detonation engine cogeneration cycles
  37. Sterols from Centaurea pumilio L. with cell proliferative activity: In vitro and in silico studies
  38. Untargeted metabolomics revealing changes in aroma substances in flue-cured tobacco
  39. Effect of pumpkin enriched with calcium lactate on iron status in an animal model of postmenopausal osteoporosis
  40. Energy consumption, mechanical and metallographic properties of cryogenically treated tool steels
  41. Optimization of ultra-high pressure-assisted extraction of total phenols from Eucommia ulmoides leaves by response surface methodology
  42. Harpin enhances antioxidant nutrient accumulation and decreases enzymatic browning in stored soybean sprouts
  43. Physicochemical and biological properties of carvacrol
  44. Radix puerariae in the treatment of diabetic nephropathy: A network pharmacology analysis and experimental validation
  45. Anti-Alzheimer, antioxidants, glucose-6-phosphate dehydrogenase effects of Taverniera glabra mediated ZnO and Fe2O3 nanoparticles in alloxan-induced diabetic rats
  46. Experimental study on photocatalytic CO2 reduction performance of ZnS/CdS-TiO2 nanotube array thin films
  47. Epoxy-reinforced heavy metal oxides for gamma ray shielding purposes
  48. Black mulberry (Morus nigra L.) fruits: As a medicinal plant rich in human health-promoting compounds
  49. Promising antioxidant and antimicrobial effects of essential oils extracted from fruits of Juniperus thurifera: In vitro and in silico investigations
  50. Chloramine-T-induced oxidation of Rizatriptan Benzoate: An integral chemical and spectroscopic study of products, mechanisms and kinetics
  51. Study on antioxidant and antimicrobial potential of chemically profiled essential oils extracted from Juniperus phoenicea (L.) by use of in vitro and in silico approaches
  52. Screening and characterization of fungal taxol-producing endophytic fungi for evaluation of antimicrobial and anticancer activities
  53. Mineral composition, principal polyphenolic components, and evaluation of the anti-inflammatory, analgesic, and antioxidant properties of Cytisus villosus Pourr leaf extracts
  54. In vitro antiproliferative efficacy of Annona muricata seed and fruit extracts on several cancer cell lines
  55. An experimental study for chemical characterization of artificial anterior cruciate ligament with coated chitosan as biomaterial
  56. Prevalence of residual risks of the transfusion-transmitted infections in Riyadh hospitals: A two-year retrospective study
  57. Computational and experimental investigation of antibacterial and antifungal properties of Nicotiana tabacum extracts
  58. Reinforcement of cementitious mortars with hemp fibers and shives
  59. X-ray shielding properties of bismuth-borate glass doped with rare earth ions
  60. Green supported silver nanoparticles over modified reduced graphene oxide: Investigation of its antioxidant and anti-ovarian cancer effects
  61. Orthogonal synthesis of a versatile building block for dual functionalization of targeting vectors
  62. Thymbra spicata leaf extract driven biogenic synthesis of Au/Fe3O4 nanocomposite and its bio-application in the treatment of different types of leukemia
  63. The role of Ag2O incorporation in nuclear radiation shielding behaviors of the Li2O–Pb3O4–SiO2 glass system: A multi-step characterization study
  64. A stimuli-responsive in situ spray hydrogel co-loaded with naringenin and gentamicin for chronic wounds
  65. Assessment of the impact of γ-irradiation on the piperine content and microbial quality of black pepper
  66. Antioxidant, sensory, and functional properties of low-alcoholic IPA beer with Pinus sylvestris L. shoots addition fermented using unconventional yeast
  67. Screening and optimization of extracellular pectinase produced by Bacillus thuringiensis SH7
  68. Determination of polyphenols in Chinese jujube using ultra-performance liquid chromatography–mass spectrometry
  69. Synergistic effects of harpin and NaCl in determining soybean sprout quality under non-sterile conditions
  70. Field evaluation of different eco-friendly alternative control methods against Panonychus citri [Acari: Tetranychidae] spider mite and its predators in citrus orchards
  71. Exploring the antimicrobial potential of biologically synthesized zero valent iron nanoparticles
  72. NaCl regulates goldfish growth and survival at three food supply levels under hypoxia
  73. An exploration of the physical, optical, mechanical, and radiation shielding properties of PbO–MgO–ZnO–B2O3 glasses
  74. A novel statistical modeling of air pollution and the COVID-19 pandemic mortality data by Poisson, geometric, and negative binomial regression models with fixed and random effects
  75. Treatment activity of the injectable hydrogels loaded with dexamethasone In(iii) complex on glioma by inhibiting the VEGF signaling pathway
  76. An alternative approach for the excess lifetime cancer risk and prediction of radiological parameters
  77. Panax ginseng leaf aqueous extract mediated green synthesis of AgNPs under ultrasound condition and investigation of its anti-lung adenocarcinoma effects
  78. Study of hydrolysis and production of instant ginger (Zingiber officinale) tea
  79. Novel green synthesis of zinc oxide nanoparticles using Salvia rosmarinus extract for treatment of human lung cancer
  80. Evaluation of second trimester plasma lipoxin A4, VEGFR-1, IL-6, and TNF-α levels in pregnant women with gestational diabetes mellitus
  81. Antidiabetic, antioxidant and cytotoxicity activities of ortho- and para-substituted Schiff bases derived from metformin hydrochloride: Validation by molecular docking and in silico ADME studies
  82. Antioxidant, antidiabetic, antiglaucoma, and anticholinergic effects of Tayfi grape (Vitis vinifera): A phytochemical screening by LC-MS/MS analysis
  83. Identification of genetic polymorphisms in the stearoyl CoA desaturase gene and its association with milk quality traits in Najdi sheep
  84. Cold-acclimation effect on cadmium absorption and biosynthesis of polyphenolics, and free proline and photosynthetic pigments in Spirogyra aequinoctialis
  85. Analysis of secondary metabolites in Xinjiang Morus nigra leaves using different extraction methods with UPLC-Q/TOF-MS/MS technology
  86. Nanoarchitectonics and performance evaluation of a Fe3O4-stabilized Pickering emulsion-type differential pressure plugging agent
  87. Investigating pyrolysis characteristics of Shengdong coal through Py-GC/MS
  88. Extraction, phytochemical characterization, and antifungal activity of Salvia rosmarinus extract
  89. Introducing a novel and natural antibiotic for the treatment of oral pathogens: Abelmoschus esculentus green-formulated silver nanoparticles
  90. Optimization of gallic acid-enriched ultrasonic-assisted extraction from mango peels
  91. Effect of gamma rays irradiation in the structure, optical, and electrical properties of samarium doped bismuth titanate ceramics
  92. Combinatory in silico investigation for potential inhibitors from Curcuma sahuynhensis Škorničk. & N.S. Lý volatile phytoconstituents against influenza A hemagglutinin, SARS-CoV-2 main protease, and Omicron-variant spike protein
  93. Physical, mechanical, and gamma ray shielding properties of the Bi2O3–BaO–B2O3–ZnO–As2O3–MgO–Na2O glass system
  94. Twofold interpenetrated 3D Cd(ii) complex: Crystal structure and luminescent property
  95. Study on the microstructure and soil quality variation of composite soil with soft rock and sand
  96. Ancient spring waters still emerging and accessible in the Roman Forum area: Chemical–physical and microbiological characterization
  97. Extraction and characterization of type I collagen from scales of Mexican Biajaiba fish
  98. Finding small molecular compounds to decrease trimethylamine oxide levels in atherosclerosis by virtual screening
  99. Prefatory in silico studies and in vitro insecticidal effect of Nigella sativa (L.) essential oil and its active compound (carvacrol) against the Callosobruchus maculatus adults (Fab), a major pest of chickpea
  100. Polymerized methyl imidazole silver bromide (CH3C6H5AgBr)6: Synthesis, crystal structures, and catalytic activity
  101. Using calcined waste fish bones as a green solid catalyst for biodiesel production from date seed oil
  102. Influence of the addition of WO3 on TeO2–Na2O glass systems in view of the feature of mechanical, optical, and photon attenuation
  103. Naringin ameliorates 5-fluorouracil elicited neurotoxicity by curtailing oxidative stress and iNOS/NF-ĸB/caspase-3 pathway
  104. GC-MS profile of extracts of an endophytic fungus Alternaria and evaluation of its anticancer and antibacterial potentialities
  105. Green synthesis, chemical characterization, and antioxidant and anti-colorectal cancer effects of vanadium nanoparticles
  106. Determination of caffeine content in coffee drinks prepared in some coffee shops in the local market in Jeddah City, Saudi Arabia
  107. A new 3D supramolecular Cu(ii) framework: Crystal structure and photocatalytic characteristics
  108. Bordeaux mixture accelerates ripening, delays senescence, and promotes metabolite accumulation in jujube fruit
  109. Important application value of injectable hydrogels loaded with omeprazole Schiff base complex in the treatment of pancreatitis
  110. Color tunable benzothiadiazole-based small molecules for lightening applications
  111. Investigation of structural, dielectric, impedance, and mechanical properties of hydroxyapatite-modified barium titanate composites for biomedical applications
  112. Metal gel particles loaded with epidermal cell growth factor promote skin wound repair mechanism by regulating miRNA
  113. In vitro exploration of Hypsizygus ulmarius (Bull.) mushroom fruiting bodies: Potential antidiabetic and anti-inflammatory agent
  114. Alteration in the molecular structure of the adenine base exposed to gamma irradiation: An ESR study
  115. Comprehensive study of optical, thermal, and gamma-ray shielding properties of Bi2O3–ZnO–PbO–B2O3 glasses
  116. Lewis acids as co-catalysts in Pd-based catalyzed systems of the octene-1 hydroethoxycarbonylation reaction
  117. Synthesis, Hirshfeld surface analysis, thermal, and selective α-glucosidase inhibitory studies of Schiff base transition metal complexes
  118. Protective properties of AgNPs green-synthesized by Abelmoschus esculentus on retinal damage on the virtue of its anti-inflammatory and antioxidant effects in diabetic rat
  119. Effects of green decorated AgNPs on lignin-modified magnetic nanoparticles mediated by Cydonia on cecal ligation and puncture-induced sepsis
  120. Treatment of gastric cancer by green mediated silver nanoparticles using Pistacia atlantica bark aqueous extract
  121. Preparation of newly developed porcelain ceramics containing WO3 nanoparticles for radiation shielding applications
  122. Utilization of computational methods for the identification of new natural inhibitors of human neutrophil elastase in inflammation therapy
  123. Some anticancer agents as effective glutathione S-transferase (GST) inhibitors
  124. Clay-based bricks’ rich illite mineral for gamma-ray shielding applications: An experimental evaluation of the effect of pressure rates on gamma-ray attenuation parameters
  125. Stability kinetics of orevactaene pigments produced by Epicoccum nigrum in solid-state fermentation
  126. Treatment of denture stomatitis using iron nanoparticles green-synthesized by Silybum marianum extract
  127. Characterization and antioxidant potential of white mustard (Brassica hirta) leaf extract and stabilization of sunflower oil
  128. Characteristics of Langmuir monomolecular monolayers formed by the novel oil blends
  129. Strategies for optimizing the single GdSrFeO4 phase synthesis
  130. Oleic acid and linoleic acid nanosomes boost immunity and provoke cell death via the upregulation of beta-defensin-4 at genetic and epigenetic levels
  131. Unraveling the therapeutic potential of Bombax ceiba roots: A comprehensive study of chemical composition, heavy metal content, antibacterial activity, and in silico analysis
  132. Green synthesis of AgNPs using plant extract and investigation of its anti-human colorectal cancer application
  133. The adsorption of naproxen on adsorbents obtained from pepper stalk extract by green synthesis
  134. Treatment of gastric cancer by silver nanoparticles encapsulated by chitosan polymers mediated by Pistacia atlantica extract under ultrasound condition
  135. In vitro protective and anti-inflammatory effects of Capparis spinosa and its flavonoids profile
  136. Wear and corrosion behavior of TiC and WC coatings deposited on high-speed steels by electro-spark deposition
  137. Therapeutic effects of green-formulated gold nanoparticles by Origanum majorana on spinal cord injury in rats
  138. Melanin antibacterial activity of two new strains, SN1 and SN2, of Exophiala phaeomuriformis against five human pathogens
  139. Evaluation of the analgesic and anesthetic properties of silver nanoparticles supported over biodegradable acacia gum-modified magnetic nanoparticles
  140. Review Articles
  141. Role and mechanism of fruit waste polyphenols in diabetes management
  142. A comprehensive review of non-alkaloidal metabolites from the subfamily Amaryllidoideae (Amaryllidaceae)
  143. Discovery of the chemical constituents, structural characteristics, and pharmacological functions of Chinese caterpillar fungus
  144. Eco-friendly green approach of nickel oxide nanoparticles for biomedical applications
  145. Advances in the pharmaceutical research of curcumin for oral administration
  146. Rapid Communication
  147. Determination of the contents of bioactive compounds in St. John’s wort (Hypericum perforatum): Comparison of commercial and wild samples
  148. Retraction
  149. Retraction of “Two mixed-ligand coordination polymers based on 2,5-thiophenedicarboxylic acid and flexible N-donor ligands: The protective effect on periodontitis via reducing the release of IL-1β and TNF-α”
  150. Topical Issue on Phytochemicals, biological and toxicological analysis of aromatic medicinal plants
  151. Anti-plasmodial potential of selected medicinal plants and a compound Atropine isolated from Eucalyptus obliqua
  152. Anthocyanin extract from black rice attenuates chronic inflammation in DSS-induced colitis mouse model by modulating the gut microbiota
  153. Evaluation of antibiofilm and cytotoxicity effect of Rumex vesicarius methanol extract
  154. Chemical compositions of Litsea umbellata and inhibition activities
  155. Green synthesis, characterization of silver nanoparticles using Rhynchosia capitata leaf extract and their biological activities
  156. GC-MS analysis and antibacterial activities of some plants belonging to the genus Euphorbia on selected bacterial isolates
  157. The abrogative effect of propolis on acrylamide-induced toxicity in male albino rats: Histological study
  158. A phytoconstituent 6-aminoflavone ameliorates lipopolysaccharide-induced oxidative stress mediated synapse and memory dysfunction via p-Akt/NF-kB pathway in albino mice
  159. Anti-diabetic potentials of Sorbaria tomentosa Lindl. Rehder: Phytochemistry (GC-MS analysis), α-amylase, α-glucosidase inhibitory, in vivo hypoglycemic, and biochemical analysis
  160. Assessment of cytotoxic and apoptotic activities of the Cassia angustifolia aqueous extract against SW480 colon cancer
  161. Biochemical analysis, antioxidant, and antibacterial efficacy of the bee propolis extract (Hymenoptera: Apis mellifera) against Staphylococcus aureus-induced infection in BALB/c mice: In vitro and in vivo study
  162. Assessment of essential elements and heavy metals in Saudi Arabian rice samples underwent various processing methods
  163. Two new compounds from leaves of Capparis dongvanensis (Sy, B. H. Quang & D. V. Hai) and inhibition activities
  164. Hydroxyquinoline sulfanilamide ameliorates STZ-induced hyperglycemia-mediated amyleoid beta burden and memory impairment in adult mice
  165. An automated reading of semi-quantitative hemagglutination results in microplates: Micro-assay for plant lectins
  166. Inductively coupled plasma mass spectrometry assessment of essential and toxic trace elements in traditional spices consumed by the population of the Middle Eastern region in their recipes
  167. Phytochemical analysis and anticancer activity of the Pithecellobium dulce seed extract in colorectal cancer cells
  168. Impact of climatic disturbances on the chemical compositions and metabolites of Salvia officinalis
  169. Physicochemical characterization, antioxidant and antifungal activities of essential oils of Urginea maritima and Allium sativum
  170. Phytochemical analysis and antifungal efficiency of Origanum majorana extracts against some phytopathogenic fungi causing tomato damping-off diseases
  171. Special Issue on 4th IC3PE
  172. Graphene quantum dots: A comprehensive overview
  173. Studies on the intercalation of calcium–aluminium layered double hydroxide-MCPA and its controlled release mechanism as a potential green herbicide
  174. Synergetic effect of adsorption and photocatalysis by zinc ferrite-anchored graphitic carbon nitride nanosheet for the removal of ciprofloxacin under visible light irradiation
  175. Exploring anticancer activity of the Indonesian guava leaf (Psidium guajava L.) fraction on various human cancer cell lines in an in vitro cell-based approach
  176. The comparison of gold extraction methods from the rock using thiourea and thiosulfate
  177. Special Issue on Marine environmental sciences and significance of the multidisciplinary approaches
  178. Sorption of alkylphenols and estrogens on microplastics in marine conditions
  179. Cytotoxic ketosteroids from the Red Sea soft coral Dendronephthya sp.
  180. Antibacterial and biofilm prevention metabolites from Acanthophora spicifera
  181. Characteristics, source, and health risk assessment of aerosol polyaromatic hydrocarbons in the rural and urban regions of western Saudi Arabia
  182. Special Issue on Advanced Nanomaterials for Energy, Environmental and Biological Applications - Part II
  183. Green synthesis, characterization, and evaluation of antibacterial activities of cobalt nanoparticles produced by marine fungal species Periconia prolifica
  184. Combustion-mediated sol–gel preparation of cobalt-doped ZnO nanohybrids for the degradation of acid red and antibacterial performance
  185. Perinatal supplementation with selenium nanoparticles modified with ascorbic acid improves hepatotoxicity in rat gestational diabetes
  186. Evaluation and chemical characterization of bioactive secondary metabolites from endophytic fungi associated with the ethnomedicinal plant Bergenia ciliata
  187. Enhancing photovoltaic efficiency with SQI-Br and SQI-I sensitizers: A comparative analysis
  188. Nanostructured p-PbS/p-CuO sulfide/oxide bilayer heterojunction as a promising photoelectrode for hydrogen gas generation
Downloaded on 30.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/chem-2022-0299/html
Scroll to top button